UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060039
Receipt number R000067727
Scientific Title Effectiveness of a Self-Care Support Mobile Application for Menopausal Symptoms in Midlife Women: A Randomized Controlled Trial
Date of disclosure of the study information 2026/01/05
Last modified on 2025/12/22 22:31:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Study on the Effectiveness of a Self-Care Support Application for Menopausal Symptoms

Acronym

Self-Care Support App Study for Menopausal Symptoms

Scientific Title

Effectiveness of a Self-Care Support Mobile Application for Menopausal Symptoms in Midlife Women: A Randomized Controlled Trial

Scientific Title:Acronym

Self-Care Support Smartphone App for Menopausal Symptoms: RCT

Region

Japan


Condition

Condition

Menopausal symptoms

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effectiveness of the self-care support app 'JoyHer Pro' for middle-aged and older women with menopausal symptoms.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of group differences in the total score of the Menopause Rating Scale (MRS) measured at baseline, 4, 8, and 12 weeks after intervention using Mixed Model for Repeated Measures (MMRM).

Key secondary outcomes

Subscales of the Menopause Rating Scale (MRS)
Simplified Menopausal Index (SMI)
Numerical Rating Scale (NRS) for symptoms such as stiff shoulders, coldness, dizziness, headache, fatigue, and weather sensitivity
Kessler 6 Psychological Distress Scale (K6)
Gastrointestinal Symptom Rating Scale (GSRS)
SF36
Work Productivity and Activity Impairment Questionnaire: General Health (WPAI-GH)
Self Compassion Scale Short Form
Knowledge, attitudes, and coping ability related to menopause
Use of medical and health services and reasons for consultations
Global improvement assessment
Blinding status
Allocation concealment awareness
Net Promoter Score (NPS)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

YES

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

The intervention group will use the JoyHer Pro app for 12 weeks.

Interventions/Control_2

The control group will use a limited-function app for 12 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

45 years-old <=

Age-upper limit

60 years-old >

Gender

Female

Key inclusion criteria

Japanese
Irregular menstrual cycles or absence of menstruation within the past year
Presence of any menopausal symptoms (Menopause Rating Scale [MRS] score of 5 or higher)
Ownership of an iPhone (iOS 16 or later) with daily availability of mobile data communication
Ability to communicate and use the app in Japanese without difficulty

Key exclusion criteria

Presence of the following comorbidities: coronary artery disease (such as angina or myocardial infarction), pheochromocytoma, psychiatric disorders (such as depression or schizophrenia), malignant tumors under treatment, uncontrolled thyroid dysfunction (with treatment changes within the last 3 months), or uncontrolled hypertension (with treatment changes within the last 3 months)
Started new medications (e.g., hormone replacement therapy or antidepressants) within the past 30 days.
Pregnant or breastfeeding.
Has previously used any of the following applications: JoyHer, JoyHer for Business, or JoyHer Pro.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Miho
Middle name
Last name Egawa

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Obstetrics and Gynecology

Zip code

606-8507

Address

54 Shogoin Kawaramachi, Sakyo-ku, Kyoto City, Japan

TEL

075-751-3284

Email

megawa@kuhp.kyoto-u.ac.jp


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Ohsuga

Organization

Graduate School of Medicine, Kyoto University

Division name

Department of Obstetrics and Gynecology

Zip code

606-8507

Address

54 Shogoin Kawaramachi, Sakyo-ku, Kyoto City, Japan

TEL

075-751-3284

Homepage URL


Email

whc6_adm@kuhp.kyoto-u.ac.jp


Sponsor or person

Institute

Kyoto university

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

YStory Inc.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee for Medical Research, Kyoto University Graduate School of Medicine and Faculty of Medicine and Kyoto University Hospital

Address

53 Shogoin-kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan

Tel

075-366-7618

Email

ethcom@kuhp.kyoto-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 11 Month 28 Day

Date of IRB


Anticipated trial start date

2026 Year 01 Month 05 Day

Last follow-up date

2027 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 10 Day

Last modified on

2025 Year 12 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067727